Publications
- Engine shutdown: Migrastatic strategies and prevention of metastases2023 | First Faculty of Medicine, Faculty of Science
- Therapeutic potential and limitations of curcumin as antimetastatic agent2023 | First Faculty of Medicine
- Combination of quinoxaline with pentamethinium system: Mitochondrial staining and targeting2023 | First Faculty of Medicine
- Pentamethinium salts suppress key metastatic processes by regulating mitochondrial function and inhibiting dihydroorotate dehydrogenase respiration2022 | First Faculty of Medicine, Faculty of Science
- The Role of IL-6 in Cancer Cell Invasiveness and Metastasis — Overview and Therapeutic Opportunities2022 | First Faculty of Medicine, Faculty of Science
- New-Generation Heterocyclic Bis-Pentamethinium Salts as Potential Cytostatic Drugs with Dual IL-6R and Mitochondria-Targeting Activity2022 | First Faculty of Medicine
- Azulene hydrazide-hydrazones for selective targeting of pancreatic cancer cells2022 | First Faculty of Medicine
- Novel Mitochondria-targeted Drugs for Cancer Therapy2021 | First Faculty of Medicine
- Circulating Tumour Cells (CTCs) in NSCLC: From Prognosis to Therapy Design2021 | First Faculty of Medicine
- Interleukin-6: Molecule in the Intersection of Cancer, Ageing and COVID-192020 | First Faculty of Medicine, Faculty of Science
Loading network view...